USD10
MNKD Shares
About MannKindMannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
USD10
MNKD Shares
About MannKindMannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease.
Stats
TRADING WINDOW
Closed
OPENS AT
Oct 14 at 1:30 PM UTC
MARKET CAP
$971.35M
OPEN PRICE
Not enough data
LOW (1Y)
$2.23
HIGH (1Y)
$6.51
LOW (24H)
$3.02
HIGH (24H)
$3.14
VOLUME (24H)
$3.08M
5.58%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $3.08 | |
1 Week | $3.64 | |
1 Month | $3.81 | |
1 Year | $5.23 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.